Cargando…
Binding-Pocket and Lid-Region Substitutions Render Human STING Sensitive to the Species-Specific Drug DMXAA
The drug DMXAA (5,6-dimethylxanthenone-4-acetic acid) showed therapeutic promise against solid tumors in mouse models but subsequently failed in human clinical trials. DMXAA was later discovered to activate mouse, but not human, STING, an adaptor protein in the cyclic dinucleotide cGAMP-mediated sig...
Autores principales: | Gao, Pu, Zillinger, Thomas, Wang, Weiyi, Ascano, Manuel, Dai, Peihong, Hartmann, Gunther, Tuschl, Thomas, Deng, Liang, Barchet, Winfried, Patel, Dinshaw J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381552/ https://www.ncbi.nlm.nih.gov/pubmed/25199835 http://dx.doi.org/10.1016/j.celrep.2014.08.010 |
Ejemplares similares
-
Discovery of Novel STING Inhibitors Based on the Structure of the Mouse STING Agonist DMXAA
por: Chang, Jiajia, et al.
Publicado: (2023) -
G-rich DNA-induced stress response blocks type-I-IFN but not CXCL10 secretion in monocytes
por: Herzner, Anna-Maria, et al.
Publicado: (2016) -
The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression
por: Weiss, Julia M., et al.
Publicado: (2017) -
The STING agonist, DMXAA, reduces tumor vessels and enhances mesothelioma tumor antigen presentation yet blunts cytotoxic T cell function in a murine model
por: Graham, Peter T., et al.
Publicado: (2022) -
RIG-I Detects Triphosphorylated RNA of Listeria monocytogenes during Infection in Non-Immune Cells
por: Hagmann, Cristina Amparo, et al.
Publicado: (2013)